Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation

    Combination of calcineurin inhibitors (CIs) with short-term methotrexate is a standard prophylactic regimen for graft-versus-host disease (GVHD). However, it is sometimes difficult to continue CIs due to adver...

    Shimpei Matsumi, Shun-ichi Kimura, Yuhei Nakamura in International Journal of Hematology (2023)

  2. No Access

    Article

    Plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1) level as a blood biomarker of neurological damage after allogeneic hematopoietic cell transplantation

    Several biofluid-based biomarkers for traumatic brain injury show promise for use in diagnosis and outcome prediction. In contrast, few studies have investigated biomarkers for non-traumatic brain injury. We f...

    Yosuke Okada, Hideki Nakasone, Kazuki Yoshimura in International Journal of Hematology (2023)

  3. No Access

    Article

    Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation

    Shun-ichi Kimura, Hiroaki Shimizu, Takuya Miyazaki in Bone Marrow Transplantation (2023)

  4. No Access

    Article

    Very early death within 30 days after diagnosis in patients with acute myeloid leukemia

    Acute myeloid leukemia (AML) is a malignancy that requires immediate treatment. However, the factors that predict very early mortality are not well known. We retrospectively analyzed 70 patients who were newly...

    Machiko Kusuda, Hideki Nakasone, Yuhei Nakamura in International Journal of Hematology (2023)

  5. Article

    Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation

    Anti-melanoma differentiation-associated gene 5 (MDA5) antibody is one of auto-immune antibodies which is associated with a rare subtype of dermatomyositis (DM), and MDA5-DM is well-characterized by rapid prog...

    Masaharu Tamaki, Shimpei Matsumi, Hideki Nakasone in Bone Marrow Transplantation (2022)

  6. No Access

    Article

    Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation

    Pancreatic atrophy after allogeneic hematopoietic cell transplantation (HCT) is one of the symptoms associated with chronic graft-versus-host disease (GVHD). Although pancreatic atrophy has been considered to cau...

    Yosuke Okada, Hideki Nakasone, Yuhei Nakamura in Journal of Gastroenterology (2022)

  7. No Access

    Article

    Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation

    High-dose cytarabine (HD-AraC) or anthracycline-containing chemotherapies are used as post-remission therapy for acute myeloid leukemia (AML) patients. However, it remains unclear which regimen would be better...

    ** Hayakawa, Hideki Nakasone, Daisuke Minakata in International Journal of Hematology (2022)

  8. No Access

    Article

    Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT

    Disease relapse is a major cause of treatment failure after allogeneic hematopoietic cell transplantation (HCT) and the mechanisms of relapse remain unclear. We encountered a 58-year-old man with chronic myelo...

    Yu Akahoshi, Hideki Nakasone, Machiko Kusuda in International Journal of Hematology (2022)

  9. No Access

    Article

    Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome

    Chromosome analysis is a powerful prognostic tool in myeloid malignancies. Recipients who experience relapse after allogeneic hematopoietic cell transplantation (allo-HCT) often show chromosomal changes betwee...

    Yosuke Okada, Hideki Nakasone, Yuhei Nakamura in Bone Marrow Transplantation (2022)

  10. Article

    Open Access

    Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents’ attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons

    The Japanese Society of Medical Oncology (JSMO) published a guideline (GL) on febrile neutropenia (FN) in 2017. This study aims to identify promoting factors and disincentives for complying with GL recommendat...

    Nobu Akiyama, Takuho Okamura, Minoru Yoshida, Shun-ichi Kimura in Supportive Care in Cancer (2022)

  11. No Access

    Article

    Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stop** calcineurin inhibitors

    Chronic graft-versus-host disease (cGVHD) of the liver is often observed in allogeneic hematopoietic stem cell transplantation (allo-HSCT) during tapering or after stop** calcineurin inhibitors (CI). We cond...

    Kazuki Yoshimura, Shun-ichi Kimura in International Journal of Hematology (2021)

  12. No Access

    Article

    Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II–IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group

    There is a matter of debate about the clinical impact of cytomegalovirus (CMV) reactivation on the development of late-onset invasive aspergillosis (IA), which occurs 40 days or later after allogeneic hematopo...

    Shun-ichi Kimura, Masaharu Tamaki, Keiji Okinaka, Sachiko Seo in Annals of Hematology (2021)

  13. No Access

    Article

    Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis

    The efficacy and clinical significance of pre-conditioning intervention (PCI) before allogeneic hematopoietic cell transplantation (HCT) in patients with acute lymphoblastic leukemia (ALL) not in remission rem...

    Takayoshi Tachibana, Junya Kanda, Takuma Ishizaki, Yuho Najima in Annals of Hematology (2021)

  14. Article

    Open Access

    A questionnaire survey on evaluation for penetration and compliance of the Japanese Guideline on Febrile Neutropenia among hematology-oncology physicians and surgeons

    The Japanese Society of Medical Oncology published a guideline (GL) on febrile neutropenia (FN) in 2017. The study’s purpose is to reveal how widely GL penetrated among physicians and surgeons providing chemot...

    Nobu Akiyama, Takuho Okamura, Minoru Yoshida, Shun-ichi Kimura in Supportive Care in Cancer (2021)

  15. Article

    Open Access

    Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation

    Cytomegalovirus reactivation is still a critical concern following allogeneic hematopoietic cell transplantation, and cellular immune reconstitution of cytomegalovirus-specific cytotoxic T-cells is necessary f...

    Hideki Nakasone, Machiko Kusuda, Kiriko Terasako-Saito in Communications Biology (2021)

  16. No Access

    Article

    Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study

    Bloodstream infection (BSI) is a frequent complication observed in patients with febrile neutropenia (FN). BSI risk factors and incidence vary depending on chemotherapy types and prophylactic antimicrobial age...

    Akinao Okamoto, Yoshinobu Kanda, Shun-ichi Kimura in International Journal of Hematology (2021)

  17. No Access

    Article

    Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation

    Although graft failure (GF) is a fatal complication after allogeneic stem cell transplantation (SCT), no mortality risk assessments after salvage SCT have been reported. We developed a comprehensive prognostic...

    Kaito Harada, Shun-ichi Kimura, Shigeo Fuji, Yuho Najima in Bone Marrow Transplantation (2021)

  18. No Access

    Article

    Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group

    We conducted a nationwide questionnaire-based survey in 2019 following 2001, 2007 and 2013 surveys to clarify the real-world management of infection during chemotherapy for acute leukemia in Japan. An online q...

    Shun-ichi Kimura, Hiroyuki Fujita, Hiroshi Handa in International Journal of Hematology (2020)

  19. No Access

    Article

    Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis

    Takayoshi Tachibana, Takuma Ishizaki, Satoshi Takahashi in Bone Marrow Transplantation (2020)

  20. No Access

    Article

    Impact of blood pressure early after allogeneic hematopoietic cell transplantation on clinical outcomes

    Allogeneic hematopoietic transplantation (allo-HCT) is still associated with significant morbidity and mortality, and risk stratification is critical. In this study, we analyzed the relationship between blood ...

    Masaharu Tamaki, Hideki Nakasone, Shunto Kawamura, Junko Takeshita in Annals of Hematology (2020)

previous disabled Page of 3